{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:20:47Z","timestamp":1778642447183,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.humpath.2013.04.018","type":"journal-article","created":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T14:27:25Z","timestamp":1374071245000},"page":"2266-2274","source":"Crossref","is-referenced-by-count":12,"title":["Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma"],"prefix":"10.1016","volume":"44","author":[{"given":"Henning","family":"Reis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremias","family":"Wohlschlaeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Katenkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef","family":"Katenkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo-Andreas","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2013.04.018_bb0005","series-title":"Soft tissue tumors","first-page":"1182","article-title":"Alveolar soft part sarcoma","author":"Weiss","year":"2008"},{"key":"10.1016\/j.humpath.2013.04.018_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-0142(19890101)63:1<1::AID-CNCR2820630102>3.0.CO;2-E","article-title":"Alveolar soft-part sarcoma. A clinico-pathologic study of half a century","volume":"63","author":"Lieberman","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2013.04.018_bb0015","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/1097-0142(20010201)91:3<585::AID-CNCR1038>3.0.CO;2-0","article-title":"Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution","volume":"91","author":"Portera","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2013.04.018_bb0020","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1158\/1078-0432.CCR-08-2050","article-title":"Response to sunitinib malate in advanced alveolar soft part sarcoma","volume":"15","author":"Stacchiotti","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2013.04.018_bb0025","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1155\/2012\/428789","article-title":"Alveolar soft part sarcomas: molecular pathogenesis and implications for novel targeted therapies","volume":"2012","author":"Mitton","year":"2012","journal-title":"Sarcoma"},{"key":"10.1016\/j.humpath.2013.04.018_bb0030","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1002\/cncr.27582","article-title":"Tivantinib (ARQ 197), a selective inhibitor of mesenchymal-epithelial transition factor, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trial","volume":"118","author":"Wagner","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2013.04.018_bb0035","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1470-2045(06)70729-X","article-title":"Vascular-endothelial-growth-factor (VEGF) expression and possible response to angiogenesis inhibitor bevacizumab in metastatic alveolar soft part sarcoma","volume":"7","author":"Azizi","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2013.04.018_bb0040","unstructured":"Keryx\/AOI Pharmaceuticals, Inc. A trial of perifosine in patients with chemo-insensitive sarcomas, 2012, clinicaltrials.gov. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00401388. Accessed January 10, 2013."},{"key":"10.1016\/j.humpath.2013.04.018_bb0045","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/MPH.0b013e3181a6e043","article-title":"Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy","volume":"31","author":"Vistica","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.humpath.2013.04.018_bb0050","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/sj.onc.1204074","article-title":"The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25","volume":"20","author":"Ladanyi","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2013.04.018_bb0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1066896909352861","article-title":"TFE3 expression in tumors of the microphthalmia-associated transcription factor (MiTF) family","volume":"19","author":"Dickson","year":"2011","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.04.018_bb0060","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cell.2008.06.048","article-title":"UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover","volume":"134","author":"Alexandru","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2013.04.018_bb0065","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1158\/0008-5472.CAN-06-2855","article-title":"TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition","volume":"67","author":"Tsuda","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2013.04.018_bb0070","doi-asserted-by":"crossref","first-page":"14071","DOI":"10.1074\/jbc.R109.094003","article-title":"Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony","volume":"285","author":"Foster","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humpath.2013.04.018_bb0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11912-012-0227-y","article-title":"PI3K and mTOR signaling pathways in cancer: new data on targeted therapies","volume":"14","author":"Willems","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.humpath.2013.04.018_bb0080","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.4161\/cbt.5.9.3175","article-title":"Therapeutic targets: MTOR and related pathways","volume":"5","author":"Dancey","year":"2006","journal-title":"Cancer Biol Ther"},{"issue":"11","key":"10.1016\/j.humpath.2013.04.018_bb0085","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1586\/era.11.154","article-title":"Targeted therapies used sequentially in metastatic renal cell cancer: overall results from a large experience","volume":"11","author":"Procopio","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.humpath.2013.04.018_bb0090","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/cncr.26361","article-title":"New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma","volume":"118","author":"Agulnik","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2013.04.018_bb0095","series-title":"World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone","first-page":"12","article-title":"Soft tissue tumours: epidemiology, clinical features, histopathological typing and grading","author":"Fletcher","year":"2002"},{"key":"10.1016\/j.humpath.2013.04.018_bb0100","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/PAS.0b013e3181dd577e","article-title":"Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma","volume":"34","author":"Zhong","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.04.018_bb0105","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1365-2559.2007.02693.x","article-title":"Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas","volume":"50","author":"Aulmann","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2013.04.018_bb0110","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/annonc\/mdq644","article-title":"Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect","volume":"22","author":"Stacchiotti","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2013.04.018_bb0115","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1479-5876-9-200","article-title":"The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas","volume":"9","author":"Valkov","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.humpath.2013.04.018_bb0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cell.2006.08.033","article-title":"SIN1\/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity","volume":"127","author":"Jacinto","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2013.04.018_bb0125","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1365-2559.2009.03436.x","article-title":"Validation of potential therapeutic targets in alveolar soft part sarcoma: an immunohistochemical study utilizing tissue microarray","volume":"55","author":"Lazar","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2013.04.018_bb0130","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1158\/1078-0432.CCR-05-1732","article-title":"Prognostic significance of activated AKT expression in soft-tissue sarcoma","volume":"12","author":"Tomita","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2013.04.018_bb0135","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/00000478-200306000-00005","article-title":"Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay","volume":"27","author":"Argani","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.04.018_bb0140","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00428-010-1039-9","article-title":"Detection of ASPL\/TFE3 fusion transcripts and the TFE3 antigen in formalin-fixed, paraffin-embedded tissue in a series of 18 cases of alveolar soft part sarcoma: useful diagnostic tools in cases with unusual histological features","volume":"458","author":"Williams","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2013.04.018_bb0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/PAT.0b013e32834d7ba4","article-title":"Alveolar soft part sarcoma 'revisited': clinicopathological review of 47 cases from a tertiary cancer referral centre, including immunohistochemical expression of TFE3 in 22 cases and 21 other tumours","volume":"44","author":"Rekhi","year":"2012","journal-title":"Pathology"},{"issue":"2","key":"10.1016\/j.humpath.2013.04.018_bb0150","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/modpathol.2011.169","article-title":"Molecular heterogeneity of TFE3 activation in renal cell carcinomas","volume":"25","author":"Macher-Goeppinger","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2013.04.018_bb0155","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/ijc.27800","article-title":"Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: clinical and molecular correlates","volume":"132","author":"Dickson","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2013.04.018_bb0160","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1038\/sj.onc.1209090","article-title":"Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease","volume":"24","author":"Astrinidis","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2013.04.018_bb0165","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/sj.onc.1209990","article-title":"Rapamycin induces feedback activation of Akt signaling through an IGF-1R\u2013dependent mechanism","volume":"26","author":"Wan","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2013.04.018_bb0170","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nature04869","article-title":"Ras, PI(3)K and mTOR signalling controls tumour cell growth","volume":"441","author":"Shaw","year":"2006","journal-title":"Nature"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817713001962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817713001962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T15:12:15Z","timestamp":1563462735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817713001962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0046817713001962"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2013.04.018","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}